Advertisement
Imaging
Subscribe to Imaging
View Sample

FREE Email Newsletter

CareFusion Launches Respiratory Airway Adapter to Improve Patient Safety and Reduce Hospital Costs

December 8, 2010 4:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Dec. 8, 2010 /- CareFusion (NYSE: CFN ), a leading, global medical device company, today announced the launch of Verso™ 90 adapter, a component that enables uninterrupted access to a ventilated patient's airway without having to disconnect the patient from the ventilator....

Texas-Based Healthcare Delivery System Expands Utilization of Streamline Health Document Workflow Solutions

December 8, 2010 4:32 am | by Bio-Medicine.Org | News | Comments

CINCINNATI, Dec. 8, 2010 /- Streamline Health Solutions, Inc. (Nasdaq: STRM ), a leading provider of document workflow solutions for hospitals, today announced that one of the largest faith-based, nonprofit healthcare delivery systems in the United States, will implement Streamline...

Winner Medical Reports Fourth Quarter and Fiscal 2010 Results

December 8, 2010 4:32 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, Dec. 8, 2010 /PRNewswire-Asia-FirstCall/ -- Fourth - Quarter 2010 Highlights Revenue increased by 2.1% over Q4 FY09 to $28.2 million Gross profit increased by 5.8% over Q4 FY09 to $8.8 million Net income increased by 5.9% over Q4 FY09 to $3.1 million with EPS of $0.13...

Advertisement

Sofie Biosciences Raises $2M to Support Development of Diagnostic Imaging Agents and Devices

December 8, 2010 4:32 am | by Bio-Medicine.Org | News | Comments

CULVER CITY, Calif., Dec. 8, 2010 /- Sofie Biosciences, a developer of agents and devices for the molecular imaging of disease, announced today the closing of an additional $2 million from new and existing investors. Funds will be used for the development of new PET imaging agents and for...

Life Spine® Announces Completion of Surgeries Utilizing OCTAVE™ Posterior Fusion System

December 8, 2010 4:32 am | by Bio-Medicine.Org | News | Comments

HOFFMAN ESTATES, Ill., Dec. 8, 2010 /- Life Spine announced today that the company has successfully completed initial cases with the OCTAVE Posterior Fusion System, which is intended for attachment to the spinous processes for the purpose of achieving fusion in conjunction with bone...

Valeritas Receives FDA 510(k) Clearance for the V-Goâ„¢ Disposable Insulin Delivery Device

December 8, 2010 4:32 am | by Bio-Medicine.Org | News | Comments

BRIDGEWATER, N.J., Dec. 8, 2010 /- Valeritas, Inc., a medical technology company committed to the development and commercialization of innovative drug delivery solutions, announced today that the US Food and Drug Administration has cleared the company's V-Go Disposable Insulin Delivery...

World Vaccine Leaders to Meet in New Delhi India to Tackle Global Public Health Challenges

December 8, 2010 3:34 am | by Bio-Medicine.Org | News | Comments

SINGAPORE, Dec. 8, 2010 /PRNewswire-Asia/ -- From the 1st to the 3rd of March 2011, vaccine leaders from developing and developed world will meet at Vaccine World Summit in New Delhi. The event will be hosted by IMAPAC, in partnership with DCVMN (Developing Countries Vaccine Manufacturers...

NYSE Amex Accepts China Shenghuo's Compliance Plan for Continued Listing

December 8, 2010 12:36 am | by Bio-Medicine.Org | News | Comments

KUNMING, China, Dec. 8, 2010 /PRNewswire-Asia-FirstCall/ -- China Shenghuo Pharmaceutical Holdings, Inc. (NYSE Amex Equities: KUN) ("China Shenghuo" or the "Company"), which is engaged in the research, development, manufacture, and marketing of pharmaceutical, nutritional supplement and...

Advertisement

China-Biotics Attended National Probiotics Seminar

December 7, 2010 2:33 am | by Bio-Medicine.Org | News | Comments

SHANGHAI, Dec. 7, 2010 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. ("China-Biotics" or "the Company"), (Nasdaq: CHBT ) the leading developer, manufacturer and distributor of probiotics products in China, today announced that a delegation from the Company's research and development...

Apexigen, Inc. Announces Collaboration for Antibody Discovery

December 7, 2010 2:33 am | by Bio-Medicine.Org | News | Comments

BURLINGAME, Calif., Dec. 7, 2010 /- Apexigen, Inc. announced today that it has entered into a collaboration and worldwide license agreement with Centocor Research & Development, Inc. and its affiliates to utilize Apexigen's proprietary therapeutic antibody technologies to discover and...

diaDexus to Present at the Canaccord Genuity Healthcare Conference

December 6, 2010 7:34 am | by Bio-Medicine.Org | News | Comments

SOUTH SAN FRANCISCO, Calif., Dec. 6, 2010 /- diaDexus, Inc. (OTC Bulletin Board: DDXS ), a diagnostics company focused on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease, today said that it plans to...

Wells Fargo Practice Finance Named Preferred Provider to the American Optometric Association's Member Advantage Program

December 6, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

EMERYVILLE, Calif., Dec. 6, 2010 /- Wells Fargo Practice Finance, formerly known as Matsco, announced today an agreement to become the preferred provider for optometric practice and equipment financing for American Optometric Association (AOA) members. The affinity relationship through...

CSL Behring Medical Product Donation Helps Meet Critical Need for Ongoing Cholera Relief Effort in Haiti

December 6, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

SANTA BARBARA, Calif., Dec. 6, 2010 /- Direct Relief International announced today that CSL Behring has donated critically needed medical supplies to assist cholera patients in Haiti. The products will be used at Justinian University Hospital (JUH) in Cap-Haitien. JUH is the main public...

Advertisement

Vermillion Reappoints Three Directors, Approves a New Stock Incentive Plan, and Ratifies PricewaterhouseCoopers LLP as Its Accounting Firm

December 6, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

AUSTIN, Texas, Dec. 6, 2010 /- Following the annual meeting of its stockholders on Friday, December 3, 2010, Vermillion, Inc. (Nasdaq: VRML ) announced that its stockholders approved the reappointment of Gail S. Page, John F. Hamilton and Dr. William C. Wallen as directors of the Company....

Purdue Pharma L.P. Re-launches Partners Against Pain Website

December 6, 2010 2:33 am | by Bio-Medicine.Org | News | Comments

STAMFORD, Conn., Dec. 6, 2010 /- Purdue Pharma L.P. unveiled an enhanced version of its popular educational website www.PartnersAgainstPain.com , making it is easier for healthcare professionals, people with pain and their caregivers to access valuable pain management information,...

PAREXEL Opens Clinical Logistics Facilities in Singapore and Russia

December 6, 2010 2:32 am | by Bio-Medicine.Org | News | Comments

BOSTON, Dec. 6, 2010 /- PAREXEL International Corporation (Nasdaq: PRXL ), a leading global biopharmaceutical services provider, today announced that it has opened two new Clinical Logistics Services facilities in emerging regions for biopharmaceutical development.   PAREXEL's new...

ConvaTec Healthcare Announces Senior Secured Notes Offering & Senior Notes Offering

December 6, 2010 2:32 am | by Bio-Medicine.Org | News | Comments

SKILLMAN, N.J., Dec. 6, 2010 /- ConvaTec Healthcare, a world-leading developer, manufacturer and marketer of innovative medical technologies for community and hospital care, today announced that in connection with a refinancing of its debt under its existing senior secured and mezzanine...

Pfizer Board of Directors Names Ian C. Read President and Chief Executive Officer

December 5, 2010 4:36 pm | by Bio-Medicine.Org | News | Comments

NEW YORK, Dec. 5, 2010 /- Pfizer Inc. (NYSE: PFE ) today announced that its Board of Directors has elected Ian C. Read, 57, currently head of the Company's global biopharmaceutical operations, as President, Chief Executive Officer and Director. Mr. Read succeeds Jeffrey B. Kindler, who...

Pharmacyclics Reports CLL Results from Preclinical and Clinical Studies of its Btk Inhibitor PCI-32765

December 5, 2010 1:33 pm | by Bio-Medicine.Org | News | Comments

ORLANDO, Fla. and SUNNYVALE, Calif., Dec. 5, 2010 /- Pharmacyclics, Inc. (Nasdaq: PCYC ) today announced data from three Chronic Lymphocytic Leukemia (CLL) presentations at the American Society of Hematology (ASH) Annual Meeting describing the Btk-selective inhibitor PCI-32765.  Two...

Portola Pharmaceuticals Announces Data Presentations Highlighting Syk/JAK Inhibitor Clinical Development Program at 52nd American Society of Hematology Annual Meeting

December 4, 2010 8:35 am | by Bio-Medicine.Org | News | Comments

SOUTH SAN FRANCISCO, Calif., Dec. 4, 2010 /- Portola Pharmaceuticals, Inc. today announced the presentation of preclinical study results for its novel Syk and JAK inhibitor program at the American Society of Hematology's 52nd Annual Meeting and Exposition. Portola's novel Syk and JAK...

IDRI Awarded Contract from BARDA to Develop Next Generation Adjuvants for Pandemic Influenza

December 3, 2010 7:35 pm | by Bio-Medicine.Org | News | Comments

SEATTLE, Dec. 4, 2010 /PRNewswire-USNewswire/ -- The Infectious Disease Research Institute (IDRI) has been awarded an $1.8 million contract from the Biomedical Advance Research and Development Authority (BARDA). IDRI's work will focus on development of adjuvant formulations with options...

Sermo Study shows 70% of Specialists are Ready to Replace Warfarin

December 3, 2010 7:38 am | by Bio-Medicine.Org | News | Comments

CAMBRIDGE, Mass., Dec. 3, 2010 /- Sermo ( http://www.sermo.com ), the world's largest online community for physicians, today announced a free Sermo Report titled, " Potential Replacements for Coumadin (warfarin) ." The report gathered feedback from physicians about awareness and...

Streamline Health to Announce Third Quarter Fiscal Year 2010 Financial Results on Wednesday, December 8

December 3, 2010 7:38 am | by Bio-Medicine.Org | News | Comments

CINCINNATI, Dec. 3, 2010 /- Streamline Health Solutions, Inc. (Nasdaq: STRM ) announced today that it will release third quarter fiscal year 2010 financial results for the period ended October 31, 2010 on Wednesday, December 8, 2010 after the market closes. The Company will conduct a...

Unilife Completes A$23.1 Million Private Placement

December 3, 2010 7:38 am | by Bio-Medicine.Org | News | Comments

LEWISBERRY, Pa., Dec. 3, 2010 /- Unilife Corporation ( Unilife or Company ) (Nasdaq: UNIS ; ASX: UNS) announced today that it has completed the A$23.1 million private placement ( Placement ), which was previously announced on 29 November 2010. Unilife issued 27,228,143 CHESS Depositary...

Regenesance Closes Financing Round

December 3, 2010 12:36 am | by Bio-Medicine.Org | News | Comments

AMSTERDAM, Dec. 2, 2010 /- Regenesance BV, an Amsterdam-based specialty pharma focusing on developing drugs to treat acute and chronic nerve disorders, announces the closure of its first seed stage financing round.  The investment was made by Life Sciences Fund Amsterdam, an...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading